Status:
TERMINATED
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
Lead Sponsor:
Pfizer
Conditions:
Endocrine System Diseases
Eligibility:
All Genders
4-14 years
Phase:
PHASE3
Brief Summary
* To evaluate the effect of increasing the growth hormone dose on the statural response * To assess the value of early treatment during the course of arthritic disease by comparing the height acquired...
Detailed Description
This trial terminated on 10-Jun-2011 due to prolonged issues with drug accountability and data collection discrepancies. The decision to terminate was not based on any safety concerns.
Eligibility Criteria
Inclusion
- This study will be proposed to all patients previously included in study CTN 97-8129-016
Exclusion
- Discontinuation of corticosteroid therapy for more than a year during study CTN 97-8129-016
- Patients withdrawing from the study prematurely
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00174291
Start Date
March 1 2002
End Date
October 1 2011
Last Update
December 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Paris, France, 75019